INDRAMEDCONSEIndraprastha Medical Corporation Limited· Healthcare ServicesHighNeutral
Announced Tue, 3 Feb, 2026 · 18:29 IST

Apollo Hospitals Delhi Q3 PAT up 25% YoY to Rs 41 cr; board updates

INDRAMEDCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.8%Reaction day
₹391.20
prior close
₹393.70
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-2.1% vs market
Hospital peers, median of 22sector+0.8%-1.6% vs sector

On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 1.6 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.4
10m
-0.5
15m
-1.7
30m
-2.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.8+1.3-2.1+0.8-1.6
Next day
-2.0+0.3-2.3-0.1-1.9
2d
-3.2-0.5-2.8+0.9-4.1
3d
-0.2+2.1-2.3+2.7-2.9
4d
+2.5+3.1-0.6+2.9-0.4
5d
+8.9+2.6+6.3+5.1+3.8
1w
+6.7+0.6+6.2+3.6+3.1
15d
+4.3-1.4+5.7+6.0-1.7
1m
-1.2-6.9+5.7+3.6-4.9
2m
+4.8-7.7+12.5+0.4+4.4
3m
+6.0+7.0-0.9+5.1+1.0
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indraprastha Apollo Hospitals posted Q3 FY26 revenue of Rs 371.6 cr, up 14% YoY, with PAT rising about 25% YoY to Rs 41 cr. For 9M FY26, revenue grew 9% to Rs 1,118 cr and PAT rose 18% to Rs 142 cr. Board noted a fresh affidavit from Delhi Govt in the pending Supreme Court case on the Sarita Vihar hospital land lease. One new independent director was appointed and three were re-appointed for 5-year terms.

Likely market impact

Strong Q3 profit growth is positive; ongoing Supreme Court case on land lease remains a key overhang for shareholders.